Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-03

Clinical Trial Update: Maintenance ElectroConvulsive Therapy in Clozapine RESISTant Schizophrenia - the MECT-RESIST Trial [NA]

View source ↗

Summary

A clinical trial evaluating maintenance electroconvulsive therapy for clozapine-resistant schizophrenia, with recruitment ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Central Institute of Mental Health, Mannheim | Conditions: Schizophrenia, Treatment Resistant Schizophrenia | NA | Status: RECRUITING